Omeros Looks To Raise $80M In Follow-On Offering
Seattle-based biopharmaceutical group Omeros Corp. on Thursday said it is looking to raise as much as $80 million in a follow-on stock offering, joining a recent surge of life sciences companies...To view the full article, register now.
Already a subscriber? Click here to view full article